Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated Review

Hodgkin lymphoma (HL) is a potentially curable lymphoma, and modern therapy is expected to successfully cure more than 80% of the patients. Second-line salvage high-dose chemotherapy and autologous stem cell transplantation (auto-SCT) have an established role in the management of refractory and rela...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Immunol Res
Main Authors: Fedele, Roberta, Martino, Massimo, Recchia, Anna Grazia, Irrera, Giuseppe, Gentile, Massimo, Morabito, Fortunato
Format: Artigo
Jezik:Inglês
Izdano: Hindawi Publishing Corporation 2015
Teme:
Review Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4695673/
https://ncbi.nlm.nih.gov/pubmed/26788526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/968212
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki